Created at	Source	Raw Value	Validated value
April 19, 2022, 4 a.m.	eu	Immunogenicity: 1) GMT fold-rise for neutralising antibodies against SARS-CoV-2 at Day 15 following a single booster dose with VLA2001 Safety: 2) Frequency and severity of solicited AEs (local and systemic reactions) within 7 days after the VLA2001 booster vaccination	Immunogenicity: 1) GMT fold-rise for neutralising antibodies against SARS-CoV-2 at Day 15 following a single booster dose with VLA2001 Safety: 2) Frequency and severity of solicited AEs (local and systemic reactions) within 7 days after the VLA2001 booster vaccination